Synthesis of a Non-Symmetrical Disorazole C₁-Analogue and Its Biological Activity

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Disorazole C1 is a potent class of cytotoxic compounds with antitumor activity.
• Existing synthetic routes often yield symmetrical analogues.
• Understanding structure-activity relationships (SAR) is crucial for developing new anticancer drugs.

Purpose of the Study:

• To develop a robust and flexible synthetic strategy for non-symmetrical disorazole analogues.
• To synthesize a novel disorazole C1 analogue containing two different heterocycles (oxazole and thiazole).
• To evaluate the cytotoxic activity and SAR of the synthesized analogue.

Main Methods:

• Convergent synthesis approach to construct the disorazole core.
• Coupling of two distinct molecular fragments, one with an oxazole and the other with a thiazole heterocycle.
• Biological evaluation of the synthesized compound for cytotoxic activity.

Main Results:

• Successfully synthesized a novel, non-symmetrical disorazole C1 analogue.
• The analogue contains both an oxazole and a thiazole heterocycle, which is highly unusual.
• The compound exhibited significant cytotoxic activity, providing valuable SAR data.

Conclusions:

• The developed synthetic route is effective for creating complex, non-symmetrical disorazole analogues.
• The novel analogue demonstrates potent antitumor potential.
• This work expands the SAR understanding of disorazole-based anticancer agents.